Literature DB >> 22219412

Incidence, predictors and outcomes of incomplete revascularization after percutaneous coronary intervention and coronary artery bypass grafting: a subgroup analysis of 3-year SYNTAX data.

Stuart J Head1, Michael J Mack, David R Holmes, Friedrich W Mohr, Marie-Claude Morice, Patrick W Serruys, A Pieter Kappetein.   

Abstract

OBJECTIVE: To assess whether incomplete revascularization by percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) has an effect on long-term outcomes.
METHODS: During a heart team discussion to evaluate whether patients were eligible for randomization in the SYNTAX trial, both the cardiologist and surgeon agreed on which vessels needed revascularization. This statement was compared with the actual revascularization after treatment. Incomplete revascularization was defined as when a preoperatively identified vessel with a lesion was not revascularized. Outcomes were major adverse cardiac or cerebrovascular events (MACCE), the composite safety endpoint of death/stroke/myocardial infarction (MI), and individual MACCE components death, MI and repeat revascularization at 3 years. Predictors of incomplete revascularization were explored.
RESULTS: Incomplete revascularization was found in 43.3% (388/896) PCI and 36.8% (320/870) CABG patients. Patients with complete revascularization by PCI had lower rates of MACCE (66.5 versus 76.2%, P < 0.001), the composite safety endpoint (83.4 versus 87.9%, P = 0.05) and repeat revascularization (75.5 versus 83.9%, P < 0.001), but not death and MI. In the CABG group, no difference in outcomes was seen between incomplete and complete revascularization groups. Incomplete revascularization was identified as independent predictor of MACCE in PCI (HR = 1.55, 95% CI 1.15-2.08, P = 0.004) but not CABG patients. Independent predictors of incomplete revascularization by PCI were hyperlipidaemia (OR = 1.59, 95% CI 1.04-2.42, P = 0.031), a total occlusion (OR = 2.46, 95% CI 1.66-3.64, P < 0.001) and the number of vessels (OR = 1.58, 95% CI 1.41-1.77, P < 0.001). Independent predictors of incomplete revascularization by CABG were unstable angina (OR = 1.42, 95% CI 1.02-1.98, P = 0.038), diffuse disease or narrowed ( < 2 mm) segment distal to the lesion (OR = 1.87, 95% CI 1.31-2.69, P = 0.001) and the number of vessels (OR = 1.70, 95% CI 1.53-1.89, P < 0.001).
CONCLUSIONS: Despite the hypothesis-generating nature of this data, this study demonstrates that incomplete revascularization is associated with adverse events during follow-up after PCI but not CABG.

Entities:  

Mesh:

Year:  2011        PMID: 22219412     DOI: 10.1093/ejcts/ezr105

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  42 in total

1.  How I choose conduits and configure grafts for my patients-rationales and practices.

Authors:  Allen Cheng; Mark S Slaughter
Journal:  Ann Cardiothorac Surg       Date:  2013-07

2.  Complete versus incomplete coronary revascularization of patients with multivessel coronary artery disease.

Authors:  Yader Sandoval; Emmanouil S Brilakis; Mariana Canoniero; Demetris Yannopoulos; Santiago Garcia
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-03

3.  A physiological approach to refine appropriateness of revascularization, clinical decision making and prognosis in patients with multi vessel coronary artery disease.

Authors:  Linle Hou; Bobby Ghosh; Abdul Hakeem
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

Review 4.  Current trends in selection of conduits for coronary artery bypass grafting.

Authors:  Thierry Carrel; Bernhard Winkler
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-08-09

5.  To complete, or not to complete, that is the question of revascularization in percutaneous coronary intervention with drug-eluting stents for multivessel disease.

Authors:  Hisato Takagi; Tomo Ando; Takuya Umemoto
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

6.  Interventional therapies in ischemic ventricular dysfunction: facts and versions!

Authors:  Paulo Cury Rezende; Diogo Freitas Cardoso de Azevedo; Whady Hueb
Journal:  Ann Transl Med       Date:  2016-10

Review 7.  Incomplete revascularization: what the surgeon needs to know.

Authors:  Dror B Leviner; Gianluca Torregrossa; John D Puskas
Journal:  Ann Cardiothorac Surg       Date:  2018-07

Review 8.  Update on the Management of Chronic Total Occlusions in Coronary Artery Disease.

Authors:  Kathleen Kearney; Ravi S Hira; Robert F Riley; Arun Kalyanasundaram; William L Lombardi
Journal:  Curr Atheroscler Rep       Date:  2017-04       Impact factor: 5.113

Review 9.  Complete versus incomplete coronary revascularization: definitions, assessment and outcomes.

Authors:  Prakriti Gaba; Bernard J Gersh; Ziad A Ali; Jeffrey W Moses; Gregg W Stone
Journal:  Nat Rev Cardiol       Date:  2020-10-16       Impact factor: 32.419

Review 10.  Medical Therapy With Versus Without Revascularization in Stable Patients With Moderate and Severe Ischemia: The Case for Community Equipoise.

Authors:  Gregg W Stone; Judith S Hochman; David O Williams; William E Boden; T Bruce Ferguson; Robert A Harrington; David J Maron
Journal:  J Am Coll Cardiol       Date:  2015-11-23       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.